- Home
- CEV vs GNTA Comparison
CEV vs GNTA Comparison
Compare CEV & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- GNTA
- Stock Information
- Founded
- CEV 1999
- GNTA 2014
- Country
- CEV United States
- GNTA Italy
- Employees
- CEV N/A
- GNTA N/A
- Industry
- CEV Finance/Investors Services
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CEV Finance
- GNTA Health Care
- Exchange
- CEV Nasdaq
- GNTA Nasdaq
- Market Cap
- CEV 70.8M
- GNTA 59.7M
- IPO Year
- CEV N/A
- GNTA 2021
- Fundamental
- Price
- CEV $10.48
- GNTA $2.23
- Analyst Decision
- CEV
- GNTA
- Analyst Count
- CEV 0
- GNTA 0
- Target Price
- CEV N/A
- GNTA N/A
- AVG Volume (30 Days)
- CEV 19.6K
- GNTA 2.0M
- Earning Date
- CEV 01-01-0001
- GNTA 01-01-0001
- Dividend Yield
- CEV 4.23%
- GNTA N/A
- EPS Growth
- CEV N/A
- GNTA N/A
- EPS
- CEV 0.36
- GNTA N/A
- Revenue
- CEV N/A
- GNTA N/A
- Revenue This Year
- CEV N/A
- GNTA N/A
- Revenue Next Year
- CEV N/A
- GNTA N/A
- P/E Ratio
- CEV $29.36
- GNTA N/A
- Revenue Growth
- CEV N/A
- GNTA N/A
- 52 Week Low
- CEV $8.83
- GNTA $2.10
- 52 Week High
- CEV $10.91
- GNTA $10.00
- Technical
- Relative Strength Index (RSI)
- CEV 75.23
- GNTA 42.95
- Support Level
- CEV $10.37
- GNTA $2.19
- Resistance Level
- CEV $10.50
- GNTA $10.00
- Average True Range (ATR)
- CEV 0.09
- GNTA 0.66
- MACD
- CEV 0.02
- GNTA -0.09
- Stochastic Oscillator
- CEV 92.52
- GNTA 2.03
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.